Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online February 28, 2007
Diabetes 56:1655-1661, 2007
DOI: 10.2337/db06-1506
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1506v1
56/6/1655    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Souza Batista, C. M.
Right arrow Articles by McLenithan, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Souza Batista, C. M.
Right arrow Articles by McLenithan, J. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Omentin Plasma Levels and Gene Expression Are Decreased in Obesity

Celia M. de Souza Batista1,2, Rong-Ze Yang1, Mi-Jeong Lee1, Nicole M. Glynn1, Dao-Zhan Yu1, Jessica Pray1, Kelechi Ndubuizu3, Susheel Patil4, Alan Schwartz4, Mark Kligman5, Susan K. Fried1,6, Da-Wei Gong1,2, Alan R. Shuldiner1,2,6, Toni I. Pollin1, and John C. McLenithan1,2,6

1 Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
2 Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland
3 Department of Biology, University of Maryland Baltimore County, Baltimore, Maryland
4 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
5 Division of General Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland
6 Geriatric Research, Education and Clinical Center, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland

Address correspondence and reprint requests to John C. McLenithan, 660 West Redwood St., Room 490, Baltimore, MD 21201. E-mail: jmcle001{at}umaryland.edu

Abbreviations: AFDS, Amish Family Diabetes Study; HOMA, homeostasis model assessment; pI, isoelectric point

Central obesity and the accumulation of visceral fat are risk factors for the development of type 2 diabetes and cardiovascular disease. Omentin is a protein expressed and secreted from visceral but not subcutaneous adipose tissue that increases insulin sensitivity in human adipocytes. To determine the impact of obesity-dependent insulin resistance on the regulation of two omentin isoforms, gene expression and plasma levels were measured in lean, overweight, and obese subjects. Omentin 1 was shown to be the major circulating isoform in human plasma. Lean subjects had significantly higher plasma omentin 1 levels than obese and overweight subjects. In addition, higher plasma omentin 1 levels were detected in women compared with men. Plasma omentin 1 levels were inversely correlated with BMI, waist circumference, leptin levels, and insulin resistance as measured by homeostasis model assessment and positively correlated with adiponectin and HDL levels. Both omentin 1 and omentin 2 gene expression were decreased with obesity and were highly correlated with each other in visceral adipose tissue. In summary, decreased omentin levels are associated with increasing obesity and insulin resistance. Therefore, omentin levels may be predictive of the metabolic consequences or co-morbidities associated with obesity.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
B. K. Tan, R. Adya, S. Farhatullah, K. C. Lewandowski, P. O'Hare, H. Lehnert, and H. S. Randeva
Omentin-1, a Novel Adipokine, Is Decreased in Overweight Insulin-Resistant Women With Polycystic Ovary Syndrome: Ex Vivo and In Vivo Regulation of Omentin-1 by Insulin and Glucose
Diabetes, April 1, 2008; 57(4): 801 - 808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.